CT SB00328 | 2020 | General Assembly
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 27 2020 - 25% progression, died in chamber
Action: 2020-03-10 - Joint Favorable
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 27 2020 - 25% progression, died in chamber
Action: 2020-03-10 - Joint Favorable
Text: Latest bill text (Introduced) [PDF]
Summary
To: (1) Require the Office of Health Strategy to establish and implement health care cost growth benchmarks in this state; (2) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (3) implement the Insurance Commissioner's recommendations regarding stop-loss insurance; and (4) require the Office of Health Strategy to seek a state innovation waiver from the federal government to establish a reinsurance program in this state and, if the federal government approves such request, implement such program in this state.
Title
An Act Concerning Health Care Cost Growth Benchmarks, Canadian Drug Reimportation, Stop-loss Insurance And Reinsurance.
Sponsors
House Insurance and Real Estate Committee | Rep. Christine Pavalock-D'Amato [R] | Rep. Kenneth Gucker [D] | Rep. Maria Horn [D] |
Sen. Martin Looney [D] | Rep. Joshua Elliott [D] | Rep. Holly Cheeseman [R] |
Roll Calls
2020-03-13 - Joint - INS Vote Tally Sheet (Joint Favorable) (Y: 16 N: 3 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2020-03-10 | Senate | Joint Favorable |
2020-03-02 | Senate | Public Hearing 03/05 |
2020-02-27 | Senate | Referred to Joint Committee on Insurance and Real Estate |